 |
PDBsum entry 1dyt
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
X-ray crystal structure of ecp (rnase 3) at 1.75 a
|
|
Structure:
|
 |
Eosinophil cationic protein. Chain: a, b. Synonym: ribonuclease 3. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Cell: eosinophil. Gene: rnase3. Expressed in: escherichia coli. Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
1.75Å
|
R-factor:
|
0.224
|
R-free:
|
0.271
|
|
|
Authors:
|
 |
G.Mallorqui-Fernandez,J.Pous,R.Peracaula,T.Maeda,H.Tada,H.Yamada, M.Seno,R.De Llorens,F.X.Gomis-Rueth,M.Coll
|
Key ref:
|
 |
G.Mallorquí-Fernández
et al.
(2000).
Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution.
J Mol Biol,
300,
1297-1307.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Feb-00
|
Release date:
|
08-Feb-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P12724
(ECP_HUMAN) -
Eosinophil cationic protein from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
160 a.a.
133 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
300:1297-1307
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution.
|
|
G.Mallorquí-Fernández,
J.Pous,
R.Peracaula,
J.Aymamí,
T.Maeda,
H.Tada,
H.Yamada,
M.Seno,
R.de Llorens,
F.X.Gomis-Rüth,
M.Coll.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Eosinophil cationic protein (ECP; RNase 3) is a human ribonuclease found only in
eosinophil leukocytes that belongs to the RNase A superfamily. This enzyme is
bactericidal, helminthotoxic and cytotoxic to mammalian cells and tissues. The
protein has been cloned, heterologously overexpressed, purified and
crystallized. Its crystal structure has been determined and refined using data
up to 1. 75 A resolution. The molecule displays the alpha+beta folding topology
typical for members of the ribonuclease A superfamily. The catalytic active site
residues are conserved with respect to other ribonucleases of the superfamily
but some differences appear at substrate recognition subsites, which may
account, in part, for the low catalytic activity. Most strikingly, 19
surface-located arginine residues confer a strong basic character to the
protein. The high concentration of positive charges and the particular
orientation of the side-chains of these residues may also be related to the low
activity of ECP as a ribonuclease and provides an explanation for its unique
cytotoxic role through cell membrane disruption.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Ribbon representation of the ECP polypep-
tide fold. The labelled helices (a1-a3), strands (b1-b6)
and loops are shown as helical ribbons, arrows and thin
tubes, respectively. Labelling is according to Figure 1.
|
 |
Figure 3.
Figure 3. View of the Connolly surfaces displaying
the electrostatic potential (ranging from
-15
kBT/e (red)
to
+15
kBT/e (blue)) of ECP (top), view into (a) and
along (b) the active site cleft, and RNase A (bottom),
view into (c) and along (d) the active site cleft.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2000,
300,
1297-1307)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Singh,
and
J.K.Batra
(2011).
Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
|
| |
Biol Chem,
392,
337-346.
|
 |
|
|
|
|
 |
M.Torrent,
M.V.Nogués,
and
E.Boix
(2011).
Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
|
| |
J Mol Recognit,
24,
90.
|
 |
|
|
|
|
 |
M.Torrent,
M.Badia,
M.Moussaoui,
D.Sanchez,
M.V.Nogués,
and
E.Boix
(2010).
Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall.
|
| |
FEBS J,
277,
1713-1725.
|
 |
|
|
|
|
 |
Z.Wang,
S.Kim,
S.K.Quinney,
J.Zhou,
and
L.Li
(2010).
Non-compartment model to compartment model pharmacokinetics transformation meta-analysis--a multivariate nonlinear mixed model.
|
| |
BMC Syst Biol,
4,
S8.
|
 |
|
|
|
|
 |
D.Sikriwal,
D.Seth,
and
J.K.Batra
(2009).
Role of catalytic and non-catalytic subsite residues in ribonuclease activity of human eosinophil-derived neurotoxin.
|
| |
Biol Chem,
390,
225-234.
|
 |
|
|
|
|
 |
D.V.Laurents,
M.Bruix,
M.A.Jiménez,
J.Santoro,
E.Boix,
M.Moussaoui,
M.V.Nogués,
and
M.Rico
(2009).
The (1)H, (13)C, (15)N resonance assignment, solution structure, and residue level stability of eosinophil cationic protein/RNase 3 determined by NMR spectroscopy.
|
| |
Biopolymers,
91,
1018-1028.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Doucet,
E.D.Watt,
and
J.P.Loria
(2009).
The flexibility of a distant loop modulates active site motion and product release in ribonuclease A.
|
| |
Biochemistry,
48,
7160-7168.
|
 |
|
|
|
|
 |
T.C.Fan,
S.L.Fang,
C.S.Hwang,
C.Y.Hsu,
X.A.Lu,
S.C.Hung,
S.C.Lin,
and
M.D.Chang
(2008).
Characterization of molecular interactions between eosinophil cationic protein and heparin.
|
| |
J Biol Chem,
283,
25468-25474.
|
 |
|
|
|
|
 |
E.Boix,
and
M.V.Nogués
(2007).
Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence.
|
| |
Mol Biosyst,
3,
317-335.
|
 |
|
|
|
|
 |
H.Yamada,
T.Tamada,
M.Kosaka,
K.Miyata,
S.Fujiki,
M.Tano,
M.Moriya,
M.Yamanishi,
E.Honjo,
H.Tada,
T.Ino,
H.Yamaguchi,
J.Futami,
M.Seno,
T.Nomoto,
T.Hirata,
M.Yoshimura,
and
R.Kuroki
(2007).
'Crystal lattice engineering,' an approach to engineer protein crystal contacts by creating intermolecular symmetry: crystallization and structure determination of a mutant human RNase 1 with a hydrophobic interface of leucines.
|
| |
Protein Sci,
16,
1389-1397.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.G.Mohan,
E.Boix,
H.R.Evans,
Z.Nikolovski,
M.V.Nogués,
C.M.Cuchillo,
and
K.R.Acharya
(2002).
The crystal structure of eosinophil cationic protein in complex with 2',5'-ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site.
|
| |
Biochemistry,
41,
12100-12106.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Maeda,
M.Kitazoe,
H.Tada,
R.de Llorens,
D.S.Salomon,
M.Ueda,
H.Yamada,
and
M.Seno
(2002).
Growth inhibition of mammalian cells by eosinophil cationic protein.
|
| |
Eur J Biochem,
269,
307-316.
|
 |
|
|
|
|
 |
J.Pous,
G.Mallorquí-Fernández,
R.Peracaula,
S.S.Terzyan,
J.Futami,
H.Tada,
H.Yamada,
M.Seno,
R.de Llorens,
F.X.Gomis-Rüth,
and
M.Coll
(2001).
Three-dimensional structure of human RNase 1 delta N7 at 1.9 A resolution.
|
| |
Acta Crystallogr D Biol Crystallogr,
57,
498-505.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |